Loading
Latest filing published 20 Apr 2026 for Milestone Pharmaceuticals Inc., €70k.
Joseph Oliveto appears in our data through filings on Milestone Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 11 July 2025 and the latest from 16 April 2026.
No open-market purchase appears, only 2 sales worth €71k. Outside the open market, there are 2 share grants. 2026 to date brings no purchases and 2 sales.
The record was last updated on 20 April 2026 with an open-market sale (€70k) in Milestone Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations